cro.directory
← Compare landing

ERGOMED Group vs Scimega Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryERGOMED GroupScimega Research
SummaryGlobal, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.
Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Oncology Specialty Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Oncology
  • Rare Disease
  • Oncology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Phase I
  • Phase II
  • Phase III
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Global Headquarters, Guildford, Surrey, United Kingdom
  • US Headquarters, Raleigh, NC, United States
  • Laval, Laval, Québec, Canada
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ERGOMED Group alternatives · Scimega Research alternatives

Markdown mirror: /compare/ergomed/scimega.md